Наукова електронна бібліотека
періодичних видань НАН України

Перегляд Experimental Oncology, 2012 (том 34) за назвою

Репозиторій DSpace/Manakin

Перегляд Experimental Oncology, 2012 (том 34) за назвою

Сортувати за: Порядок: Результатів:

  • Chaklader, M.; Das, P.; Pereira, J.A.; Law, A.; Chattopadhyay, S.; Chatterjee, R.; Mondal, A.; Law, S. (Experimental Oncology, 2012)
    Aim: Peritoneal or retro-peritoneal sarcomatosis related malignant ascites formation is a rare but serious consequence of the locoregional metastatic event. The present work aimed to study the effect of the Hsp90 inhibitor ...
  • Myshunina, T.M.; Kalinichenko, O.V.; Tronko, N.D. (Experimental Oncology, 2012)
    Aim: The aim of this study was to evaluate the frequency of existence of thyroid extratumoral normo- and microfollicular tissue in patients with thyroid carcinoma and peculiarities of apoptosis in mentioned tissue. Materials ...
  • Wu, P.C.; Wang, Q.; Grobman, L.; Chu, E.; Wu, D.Y. (Experimental Oncology, 2012)
    Accelerated cellular senescence (ACS) is an emerging concept that implicates sustained, telomere-independent cell cycle arrest of neoplastic cells in response to chemotherapeutic agents, ionizing radiation, oxidative stress, ...
  • Vasilyeva, E.D.; Kaledin, V.; Nikolin, V.P.; Popova, N.A.; Kirilyuk, I.A.; Grigor`ev, I.A. (Experimental Oncology, 2012)
    Aim: A recently discovered enzyme, indoleamine 2,3-dioxygenase (IDO), is expressed in placenta, dendritic cells and also in many kinds of tumors and in tumor-infiltrating macrophages. By catabolizing tryptophan, IDO causes ...
  • Yalcin, T.J.; Haimovitz-Friedman, A.; Verheij, M. (Experimental Oncology, 2012)
    Early response prediction is considered an essential tool to obtain a more customized anticancer treatment because it allows for the identification of patients who will benefit most from a particular therapy and prevents ...
  • Gambashidze, K.; Khorava, P.; Azaladze, T.; Kalandarishvili, K.; Jaiani, E.; Lasareishvil, B.; Azaladze, A.; Tediashvili, M. (Experimental Oncology, 2012)
    Aim: To augment anti-tumor host response and overcome the tumor-induced immunosuppression is of paramount importance especially when patient is subjected to radio-/chemotherapy and immune system suffers significantly. ...
  • Balcer-Kubiczek, E.K. (Experimental Oncology, 2012)
    Radiation therapy achieves its therapeutic effects by inducing apoptosis and non-apoptotic cell death. The aim of this focused review is to highlight the aspects of the cell death pathways most relevant to conventional ...
  • Bazyka, D.A.; Prysyazhnyuk, A.Ye.; Romanenko, A.Ye.; Fedorenko, Z.P.; Gudzenko, N.A.; Fuzik, M.M.; Khukhrianska, O.M.; Trotsyuk, N.K.; Gulak, L.O.; Goroch, Ye.L.; Sumkina, Ye.V. (Experimental Oncology, 2012)
    The study goal was to investigate malignant tumors incidence in 5 Ukrainian cities with nuclear hazardous enterprises: extractive, processing enterprises of uranium ore (Zhovti Wody and Dniprodzerzhynsk of Dnipropetrovsk ...
  • Giesel, F.L.; Mehndiratta, A.; Mafomane, M.P.; Zechmann, C.M.; Bergmann, F.; Schemmer, P.; Haberkorn, U.; Kratochwil, C. (Experimental Oncology, 2012)
    Detection and resection of small neuroendocrine tumours (NET) is like finding a needle in a hay stack. Use of specific tracers such as 68Ga-DOTATOC in a PET/CT study has been proven to have a high sensitivity and specificity ...
  • Crowder, R.N.; El-Deiry, W.S. (Experimental Oncology, 2012)
    Research on TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors has advanced tremendously over the past 17 years. Initial observations of TRAIL and TRAIL receptor-mediated tumor cell toxicity led to enthusiasm ...
  • Fiandalo, M.V.; Kyprianou, N. (Experimental Oncology, 2012)
    Emergence of castration-resistant metastatic prostate cancer is due to activation of survival pathways, including apoptosis suppression and anoikis resistance, and increased neovascularization. Thus targeting of apoptotic ...
  • Safa, A.R. (Experimental Oncology, 2012)
    Cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein (c-FLIP) is a master anti-apoptotic regulator and resistance factor that suppresses tumor necrosis factor-α (TNF-α), Fas-L, and TNF-related apoptosis-inducing ...
  • Ryabchenko, N.M.; Glavin, O.A.; Shtefura, V.V.; Anikusko, M.F. (Experimental Oncology, 2012)
    Aim: Recent studies showed that increased chromosomal damage induced by ionizing radiation is observed among patients with different tumor types. The aim of the study was evaluation of chromosomal radiosensitivity in breast ...
  • Kriachok, I.A. (Experimental Oncology, 2012)
  • Gamaleia, N.F.; Lisnyak, I.A.; Shishko, E.D.; Mamchur, A.A.; Prokopenko, I.V.; Kholin, V.V. (Experimental Oncology, 2012)
    In research of the last decade, rhythmic (circadian) variations of vascular endothelial growth factor (VEGF) production by tumors were discovered. The present paper authors have earlier synthesized and characterized a new ...
  • Monian, P.; Jiang, X. (Experimental Oncology, 2012)
    In mammalian cells, the mitochondrial pathway of apoptosis plays a key role in various biological processes and has been extensively studied. One of the signature features of this pathway is permeabilization of the outer ...
  • Yefimova, S.L.; Kurilchenko, I.Yu.; Tkacheva, T.N.; Rozhkov, V.A.; Sorokin, A.V.; Lukianova, N.Yu.; Bezdenezhnykh, N.A.; Malyukin, Yu.V.; Chekhun, V.F. (Experimental Oncology, 2012)
    The aim of this research is to study the dynamics and efficiency of liposome accumulation in sensitive and resistant human breast cancer cells. Methods: Methods of fluorescence microscopy, fluorescence microspectroscopy ...
  • Melnikov, A.A.; Vasilyev, S.A.; Musabaeva, L.I.; Velikaya, V.V.; Gribova, O.V.; Startseva, Zh.A.; Urazova, L.N.; Lebedev, I.N.; Choynzonov, E.L. (Experimental Oncology, 2012)
    Aim:To assess the frequency and spectrum of chromosome aberrations and micronuclei in peripheral blood lymphocytes of patients with parotid salivary gland tumors and relapse of breast cancer during the course of neutron ...
  • Wlodkowic, D.; Skommer, J.; Darzynkiewicz, Z. (Experimental Oncology, 2012)
    Characteristic changes in cell morphology paralleled by the appearance of a multitude of molecular and biochemical markers occur during apoptosis. These changes vary depending on the cell type, mechanism of induction of ...
  • Tserkovsky, D.A.; Alexandrova, E.N.; Chalau, V.N.; Istomin, Yu.P. (Experimental Oncology, 2012)
    The aim of this study was to investigate the low-power density sonication, sonodynamic therapy (SDT) with Photolon and combination of SDT and photodynamic therapy (PDT) with Photolon for the ablation of glioma C6 tumor ...

Пошук


Розширений пошук

Перегляд

Мій обліковий запис